T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding T2 Biosystems, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 76 | 2 | 68 | −6 |
| Shares | 15.3M | 50.6K | 19.0M | +3.78M (+24.9%) |
| Value | $7.97M | $18.0K | $3.07M | −$4.89M (−61.4%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Charles Schwab Investment Management Inc | 170,096 | $28.0K | 0.00% |
| Two Sigma Securities, LLC | 19,855 | $3.00K | 0.00% |
| Meridian Financial, LLC | 10,000 | $1.61K | 0.00% |
| Harbour Investments, Inc. | 40 | $0 | 0.00% |
| CWM, LLC | 335 | $0 | 0.00% |
Sold out (11)
Institutions that held T2 Biosystems, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Principal Financial Group Inc | 177,785 | $93.0K |
| HRT Financial LP | 35,692 | $18.0K |
| Jane Street Group, LLC | 29,381 | $15.0K |
| Ameriprise Financial Inc | 20,006 | $10.0K |
| Citigroup Inc | 20,000 | $10.0K |
| Claro Advisors LLC | 16,703 | $9.00K |
| Koshinski Asset Management, Inc. | 8,650 | $4.53K |
| Bollard Group LLC | 2,908 | $2.00K |
| Cutler Group LP | 2,480 | $1.00K |
| High Net Worth Advisory Group LLC | 2,000 | $1.00K |
| Captrust Financial Advisors | 5 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held T2 Biosystems, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| WealthPLAN Partners, LLC | 25,300 | $9.00K |
| WealthPlan Investment Management, LLC | 25,300 | $9.00K |